This handout is for gout (acute flare → urate-lowering therapy). Your care team identified this based on: acute monoarthritis, often 1st mtp (podagra) (acr 2020 fitzgerald; eular 2024).
Other reasons your team may use this plan: polyarticular flare with prior gout (acr 2020 fitzgerald); hyperuricemia + recurrent flares / tophi / urolithiasis (acr 2020 fitzgerald); tophi on exam / dual-energy ct (eular 2024).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| colchicine | — | — | — | 1.2 mg → 0.6 mg 1h later — low-dose colchicine per AGREE trial (Terkeltaub Arthritis Rheum 2010); ACR 2020 FitzGerald strong; 0.6 mg q12h or daily until resolution |
| naproxen | — | — | — | 500 mg BID × 5-7 d; alternative indomethacin 50 mg TID (ACR 2020 FitzGerald first-line) |
| prednisone | — | — | — | 40 mg/d × 5 d or 0.5 mg/kg/d taper over 10-14 d (ACR 2020 FitzGerald first-line; EULAR 2024) |
| anakinra | — | — | — | 100 mg SC daily × 3-5 d (off-label, ACR 2020 FitzGerald conditional; EULAR 2024) |
Plan: Acute gout flare (≤24 h symptom onset)
Use these zones to know what to do based on how you feel.
Call 911 or go to the nearest emergency room right away if you have:
Lifelong ULT for established gout (ACR 2020 FitzGerald strong); CV risk modification; counsel on diet (alcohol, fructose, organ meats), weight, hydration (EULAR 2024); tophus-specific surgery referral if functional impairment
Guideline: 2020 ACR Guideline for Gout (FitzGerald et al, Arthritis Care Res 2020) + 2024 EULAR Updated Recommendations (Richette et al) + ACP 2017